Egyptian Rheumatologist

Scope & Guideline

Advancing rheumatology through open dialogue.

Introduction

Welcome to your portal for understanding Egyptian Rheumatologist, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1110-1164
PublisherELSEVIER
Support Open AccessYes
CountryEgypt
TypeJournal
Convergefrom 2011 to 2024
AbbreviationEGYPT RHEUMATOL / Egypt. Rheumatol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The Egyptian Rheumatologist journal is dedicated to advancing knowledge in the field of rheumatology, focusing on the diagnosis, treatment, and management of various rheumatic diseases. The journal's scope encompasses a wide range of topics, emphasizing both clinical and translational research.
  1. Clinical Characteristics and Management of Rheumatic Diseases:
    The journal frequently publishes studies detailing the clinical features, management strategies, and outcomes of various rheumatic conditions, including systemic lupus erythematosus, rheumatoid arthritis, and spondyloarthritis.
  2. Biomarkers and Genetic Studies:
    Research on biomarkers, genetic variations, and their implications in rheumatic diseases is a core focus, with numerous papers exploring the role of interleukins and other molecular markers in disease activity and treatment response.
  3. Ultrasound and Imaging Techniques:
    The use of imaging modalities, particularly musculoskeletal ultrasound and MRI, is a significant area of interest, contributing to the understanding of disease activity, diagnosis, and treatment evaluation in rheumatology.
  4. Comorbidities and Extra-Articular Manifestations:
    The journal addresses the impact of comorbid conditions and extra-articular manifestations of rheumatic diseases, emphasizing the holistic management of patients.
  5. Patient Quality of Life and Psychosocial Aspects:
    There is a consistent focus on the quality of life, mental health issues, and psychosocial aspects related to rheumatic diseases, highlighting the importance of comprehensive care.
The Egyptian Rheumatologist has demonstrated a dynamic evolution in its research themes, particularly in recent years. Several emerging trends reflect the current priorities and innovations in the field of rheumatology.
  1. Role of Genetics and Molecular Biology:
    There is a growing trend towards exploring the genetic and molecular underpinnings of rheumatic diseases, with an emphasis on identifying genetic polymorphisms and their associations with disease susceptibility and treatment outcomes.
  2. Integrated Care Models:
    Emerging studies are focusing on integrated care models that address the multifaceted aspects of rheumatic diseases, including physical, psychological, and social dimensions of patient care.
  3. Impact of COVID-19 on Rheumatic Patients:
    The pandemic has prompted an increase in research examining the effects of COVID-19 on patients with rheumatic diseases, including the implications of vaccination and infection outcomes.
  4. Use of Advanced Imaging Techniques:
    The application of advanced imaging techniques, particularly ultrasound and MRI, for better diagnosis and monitoring of disease activity is increasingly prevalent in recent publications.
  5. Psychosocial Factors and Quality of Life:
    There is an emerging focus on the psychosocial factors affecting patients with rheumatic diseases, emphasizing the need to address mental health and quality of life in treatment paradigms.

Declining or Waning

While the Egyptian Rheumatologist continues to explore a variety of significant themes, some areas of research have seen a notable decline in focus over recent years. These waning scopes may reflect shifts in research priorities or the maturation of existing knowledge.
  1. Traditional Pharmacological Treatments:
    There is a noticeable decline in studies focusing solely on traditional pharmacological treatments for rheumatic diseases, as the journal increasingly emphasizes personalized medicine and newer therapeutic approaches.
  2. Epidemiological Studies:
    Research centered on the epidemiology of rheumatic diseases appears to be less prominent, possibly due to a shift towards more mechanism-based and patient-centered studies.
  3. Basic Science Research:
    There seems to be a waning interest in basic science research without direct clinical implications, as the journal prioritizes translational studies that bridge laboratory findings with clinical applications.

Similar Journals

LUPUS

Pioneering innovative research in lupus and beyond.
Publisher: SAGE PUBLICATIONS LTDISSN: 0961-2033Frequency: 14 issues/year

LUPUS is a premier peer-reviewed journal published by SAGE Publications Ltd, focusing on the field of rheumatology, with a specific emphasis on the complexities of lupus and related autoimmune disorders. Since its inception in 1991, the journal has consistently ranked in the Q2 category within the rheumatology field, currently positioned as #29 out of 73 in Scopus, reflecting its significant contributions to research and clinical practice. The journal aims to foster a deeper understanding of lupus through the publication of original research articles, reviews, and clinical studies, making it an essential resource for researchers, clinicians, and students dedicated to advancing knowledge in this vital area of medicine. With an impact factor that underscores its influence, LUPUS serves as a critical platform for sharing innovative findings and engaging discussions within the global scientific community. Although the journal follows a traditional access model, it is situated in the United Kingdom, at 1 Olivers Yard, 55 City Road, London EC1Y 1SP, England, and remains dedicated to supporting the continuous advancement of research in autoimmune diseases.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Transforming clinical practice with authoritative knowledge.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-857XFrequency: 4 issues/year

Rheumatic Disease Clinics of North America is a premier journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of rheumatology through comprehensive and impactful research. With an ISSN of 0889-857X and an E-ISSN of 1558-3163, this esteemed publication has been disseminating knowledge since its inception in 1987, and continues to guide clinicians and researchers alike through its insightful articles and case studies. Positioned in the 2023 Q2 quartile for Rheumatology, it ranks #31 out of 73 journals in the Scopus category of Medicine _ Rheumatology, reflecting a commendable impact factor and relevance in the academic community. Although it does not offer open access options, the journal ensures that subscribers have access to cutting-edge research and reviews that address contemporary challenges and advancements in rheumatic disease. With its authoritative content, Rheumatic Disease Clinics of North America serves as a vital resource for those striving to improve patient care and clinical outcomes in the ever-evolving landscape of rheumatology research.

RHEUMATOLOGY INTERNATIONAL

Unraveling the complexities of immunology and rheumatology.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Elevating research standards in arthritis and rheumatism.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

SKELETAL RADIOLOGY

Bridging Research and Clinical Practice in Skeletal Radiology
Publisher: SPRINGERISSN: 0364-2348Frequency: 12 issues/year

Skeletal Radiology, published by Springer, is a preeminent journal dedicated to the field of radiology, specifically focusing on the anatomical and pathological aspects of the skeletal system. Covering a breadth of topics from imaging techniques to innovative diagnostic methodologies, it aims to enhance knowledge and expertise in the interpretation of musculoskeletal conditions. Operating under the ISSN 0364-2348 and E-ISSN 1432-2161, the journal has established itself as a key resource for researchers, clinicians, and medical professionals, boasting an impressive impact factor that reflects its scholarly significance. As of 2023, it holds a commendable ranking in the Q2 quartile for Radiology, Nuclear Medicine and Imaging, and ranks #123 out of 333 in the Scopus database, placing it in the 63rd percentile. With a history spanning from 1976 to 2024, this journal continually seeks to publish high-quality research that advances the understanding of skeletal radiology. While it does not currently offer Open Access options, its rigorous peer-review process ensures that only the most relevant and impactful studies are shared with the global academic community.

Revista Cubana de Reumatologia

Fostering innovation in the management of rheumatic conditions.
Publisher: SOC CUBANA REUMATOLOGIAISSN: 1606-5581Frequency: 2 issues/year

Revista Cubana de Reumatologia is a prominent open-access journal published by the SOC CUBANA REUMATOLOGIA, dedicated to advancing knowledge in the field of rheumatology since its inception in 1998. With an ISSN of 1606-5581 and an E-ISSN of 1817-5996, this journal aims to disseminate high-quality research that addresses various aspects of rheumatic diseases, their diagnosis, treatment, and management. Located in Havana, Cuba, the journal serves as a vital platform for both local and international researchers, professionals, and students interested in the latest developments within the specialty. By embracing an open-access policy, the journal ensures that groundbreaking studies are freely available to a global audience, fostering collaboration and innovation in rheumatological research. As the field continues to evolve, Revista Cubana de Reumatologia remains committed to addressing the emerging challenges and trends, making it an essential resource for practitioners and scholars alike.

Egyptian Journal of Pediatric Allergy and Immunology

Connecting researchers and practitioners for a healthier future.
Publisher: EGYPTIAN SOC PEDIATRIC ALLERGY & IMMUNOLOGYISSN: 1687-1642Frequency: 2 issues/year

Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.

Lancet Rheumatology

Pioneering insights for the future of rheumatological care.
Publisher: ELSEVIERISSN: 2665-9913Frequency: 12 issues/year

The Lancet Rheumatology, published by Elsevier, is a premier academic journal dedicated to advancing the understanding of rheumatology and immunological diseases. Launched in 2019, this esteemed publication has quickly become a leading source of research, achieving an impressive Q1 ranking in both the fields of Rheumatology and Immunology as of 2023. With Scopus rankings placing it at #2 out of 73 in Medicine - Rheumatology and #6 out of 233 in Medicine - Immunology and Allergy, the journal serves as an essential platform for disseminating high-quality, peer-reviewed articles that address the latest findings and clinical practices in these domains. The journal, accessible in print and online, is committed to fostering knowledge and collaboration among researchers, healthcare professionals, and students alike, making it an invaluable resource for those seeking to deepen their expertise in rheumatology and its interrelated fields.

CURRENT OPINION IN RHEUMATOLOGY

Connecting Researchers with Pioneering Discoveries
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8711Frequency: 6 issues/year

Current Opinion in Rheumatology, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of rheumatology. Since its inception in 1989, this prestigious journal has been at the forefront of disseminating cutting-edge research, with a notable Q1 ranking in the 2023 Rheumatology category and an impressive Scopus rank of 7 out of 73, placing it in the 91st percentile. The journal's commitment to presenting insightful reviews and critical analyses of recent advancements and treatment strategies makes it an essential read for professionals, researchers, and students dedicated to the study of rheumatic diseases. Although not an open-access journal, Current Opinion in Rheumatology continues to foster an informed dialogue within the academic community through its high-impact content, ensuring that the latest developments and practices are accessible to those at the vanguard of rheumatology research.

JOINT BONE SPINE

Pioneering research for better patient outcomes.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 1297-319XFrequency: 6 issues/year

JOINT BONE SPINE is a premier peer-reviewed journal dedicated to advancing knowledge in the fields of rheumatology and orthopedics. Published by Elsevier France-Editions Scientifiques Medicales Elsevier, this esteemed journal has established itself as a key resource within the academic community, being categorized in the Q2 quartile of rheumatology journals for 2023. With an impressive impact as denoted by its Scopus rank of #26 out of 73, and a noteworthy 65th percentile, JOINT BONE SPINE serves as a vital platform for innovative research and clinical findings that address bone and joint diseases. The journal promotes open access, which enhances the dissemination of research findings, ensuring that practitioners, researchers, and students alike can easily access the latest developments and methodologies in the field. With a commitment to bridging scientific advances from 2000 to the present and beyond, JOINT BONE SPINE plays a critical role in shaping the future of musculoskeletal medicine and improving patient outcomes worldwide.